About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Ovarian Cancer Clinical Trials | 4,038 Studies Recruiting

Clinical TrialsOvarian Cancer

Ovarian Cancer Clinical Trials

Browse 4,038 clinical trials for ovarian cancer. Find studies that match your criteria and connect with research centers.

Find trials near:

New York Los Angeles Chicago Houston Phoenix Philadelphia

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 461-480 of 4,038 trials

CompletedGenetic Risk: Whether, When, and How to Tell AdolescentsThis study is being conducted to learn more about family communication of genetic risk information.NCT03421327·Baltimore, Maryland CompletedPlatinum-based Chemotherapy With Atezolizumab and Niraparib in Patients With Recurrent Ovarian CancerAtezolizumab in this study is expected to have a positive benefit-risk profile for the treatment of patients with platinum-sensitive relapse of ovarian cancer.NCT03598270·Charleroi and 70 others

Related Searches

ovary cancertrials

Data from ClinicalTrials.govTerms

CompletedImmunotherapy in Treating Patients Who Are Undergoing Bone Marrow or Peripheral Stem Cell TransplantationRATIONALE: White blood cells from donors who have been exposed to cytomegalovirus may be able to help prevent this infection from occurring in patients who are undergoing bone…NCT00002673·Seattle, Washington

RecruitingA Non-interventional Registry Study of Fluzoparib in the Treatment of Ovarian CancerOvarian cancer is one of the most fatal malignant tumors that threaten women's health.NCT05206890·Wuhan, Hubei

TerminatedStudy of Pembrolizumab With or Without CC-486 in Patients With Platinum-resistant Ovarian CancerThe purpose of the study is to determine the optimal dose of CC-486 (oral azacitidine) in combination with pembrolizumab for the treatment of platinum-resistant/refractory…NCT02900560·Los Angeles, California and 3 others

CompletedThe Lifestyle and Empowerment Techniques in Survivorship of Gynecologic Oncology StudyThis study compares traditional follow-up of gynaecological cancer patients to an alternative follow-up model.NCT04122235·Gjøvik, Oppland and 11 others

TerminatedVM110 in Detection of Microscopic Tumors: A Phase I StudyA laproscopic imaging tecgnology that uses a synthetic agent to detect ovarian and pancreatic cancers at an early stage so that patients can get treatment early and prevent the…NCT03286062·Philadelphia, Pennsylvania

Active not recruitingOlaparib Maintenance Monotherapy in Patients With BRCA Mutated Ovarian Cancer Following First Line Platinum Based Chemotherapy.Olaparib Monotherapy in Patients with BRCA Mutated Ovarian Cancer following First Line Platinum Based Chemotherapy.NCT01844986·Huntsville, Alabama and 176 others

RecruitingImmunotherapy Platform Study in Platinum Resistant High Grade Serous Ovarian CancerThis study is being done to answer the following question: What are the effects of a new drug or drugs on ovarian cancer?NCT04918186·Chicago, Illinois and 5 others

Not yet recruitingA Study of XS-02 Capsules in Patients With Advanced Solid TumorsA study to evaluate the safety, tolerability, Pharmacokinetics(pk), and efficacy of XS-02 capsules in patients with advanced solid tumors.NCT06531486

WithdrawnA Study of ASP1893 in Adults With Advanced CLDN6-positive Solid TumorsBefore a treatment can be approved for use, clinical studies need to be done.NCT06681870

CompletedBupropion Hydrochloride in Improving Sexual Desire in Women With Breast or Gynecologic CancerThis phase II randomized trial studies how well bupropion hydrochloride works in improving sexual desire in women with breast or gynecological cancer.NCT03180294·Anaheim, California and 361 others

UnknownA Study of SHR-A1921 With or Without Carboplatin in Subjects With Ovarian CancerThis is an open-label, randomized, controlled, two-part study to evaluate the safety and efficacy of SHR-A1921 with or without carboplatin verus investigator's choice of…NCT06211023

CompletedA Dose Escalation Study Of PF-06801591 In Melanoma, Head And Neck Cancer (SCCHN), Ovarian, Sarcoma, Non-Small Cell Lung Cancer, Urothelial Carcinoma or Other Solid TumorsProtocol B8011001 is a Phase 1, open-label, multi-center, multiple-dose, dose escalation and expansion, safety, pharmacokinetics (PK), and pharmacodynamics (PD) study of…NCT02573259·Los Angeles, California and 66 others

CompletedFeasibility Study of Pazopanib in Combination With Chemotherapy in Gynaecological TumorsThis is an open-label, two-arm, multicenter feasibility study to evaluate the safety and tolerability of pazopanib in combination with carboplatin and paclitaxel in female…NCT00561795·Lyon and 4 others

CompletedPhase Ib/II Study of Carboplatin + M6620 + Avelumab in PARPi-resistant Ovarian CancerThe study was to evaluate the efficacy and safety of avelumab in combination with M6620 + carboplatin in participants with PARPi-resistant, recurrent, platinum sensitive ovarian…NCT03704467·Greenbrae, California and 12 others

CompletedA Study of IMP4297 in Patients With Advanced Solid TumorsThis is a Phase I, first-in-human, open-label, dose-escalation study of IMP4297 administered orally once every day to patients with advanced solid tumors for whom standard therapy…NCT03508011·Beijing, Beijing Municipality and 1 other

CompletedGefitinib in Treating Patients With Recurrent or Persistent Ovarian Epithelial Cancer or Primary Peritoneal CancerRATIONALE: Biological therapies such as gefitinib may interfere with the growth of the tumor cells and may slow the growth of ovarian epithelial cancer or primary peritoneal…NCT00023699·Birmingham, Alabama and 52 others

TerminatedDose Escalation and Efficacy Study of mRNA-2416 for Intratumoral Injection Alone and in Combination With Durvalumab for Participants With Advanced MalignanciesThis clinical study will assess the safety and tolerability of escalating doses of mRNA-2416 alone and in combination with administered fixed doses of durvalumab in participants…NCT03323398·Aurora, Colorado and 8 others

Active not recruitingEvaluating an Alternative Clinical Genetics Cancer Care Delivery Model: A Pilot Study of Patient OutcomesThis study will evaluate patients' experiences with having gynecologic or prostate medical oncologists and surgeons offer them genetic testing, and having genetic counselors…NCT02917798·Basking Ridge, New Jersey and 4 others

PreviousPage 24 of 202Next